Global CRISPR and CRISPR Associated(CAS Genes) Market Research Report 2023(Status and Outlook)

Global CRISPR and CRISPR Associated(CAS Genes) Market Research Report 2023(Status and Outlook)



Report Overview

This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.

Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of ""spacer DNA"" from previous exposures to a bacteriophage virus or plasmid.

The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.

Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.

By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.

The Global CRISPR and CRISPR Associated(CAS Genes) Market Size was estimated at USD 1384.40 million in 2022 and is projected to reach USD 9615.57 million by 2029, exhibiting a CAGR of 31.90% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global CRISPR and CRISPR Associated(CAS Genes) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global CRISPR and CRISPR Associated(CAS Genes) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the CRISPR and CRISPR Associated(CAS Genes) market in any manner.

Global CRISPR and CRISPR Associated(CAS Genes) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Thermo Fisher Scientific

Editas Medicine

Caribou Biosciences

CRISPR therapeutics

Intellia therapeutics, Inc.

Cellectis

Horizon Discovery Plc

Sigma Aldrich

Precision Biosciences

Genscript

Sangamo Biosciences Inc.

Lonza Group Limited

Integrated DNA Technologies

New England Biolabs

Origene Technologies

Market Segmentation (by Type)

Genome Editing

Genetic engineering

gRNA Database/Gene Librar

CRISPR Plasmid

Human Stem Cells

Genetically Modified Organisms/Crops

Cell Line Engineering

CRISPR and CRISPR-Associated (Cas)

Market Segmentation (by Application)

CAPD

APD

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the CRISPR and CRISPR Associated(CAS Genes) Market

Overview of the regional outlook of the CRISPR and CRISPR Associated(CAS Genes) Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of CRISPR and CRISPR Associated(CAS Genes)
1.2 Key Market Segments
1.2.1 CRISPR and CRISPR Associated(CAS Genes) Segment by Type
1.2.2 CRISPR and CRISPR Associated(CAS Genes) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CRISPR and CRISPR Associated(CAS Genes) Market Overview
2.1 Global Market Overview
2.1.1 Global CRISPR and CRISPR Associated(CAS Genes) Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global CRISPR and CRISPR Associated(CAS Genes) Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CRISPR and CRISPR Associated(CAS Genes) Market Competitive Landscape
3.1 Global CRISPR and CRISPR Associated(CAS Genes) Sales by Manufacturers (2018-2023)
3.2 Global CRISPR and CRISPR Associated(CAS Genes) Revenue Market Share by Manufacturers (2018-2023)
3.3 CRISPR and CRISPR Associated(CAS Genes) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global CRISPR and CRISPR Associated(CAS Genes) Average Price by Manufacturers (2018-2023)
3.5 Manufacturers CRISPR and CRISPR Associated(CAS Genes) Sales Sites, Area Served, Product Type
3.6 CRISPR and CRISPR Associated(CAS Genes) Market Competitive Situation and Trends
3.6.1 CRISPR and CRISPR Associated(CAS Genes) Market Concentration Rate
3.6.2 Global 5 and 10 Largest CRISPR and CRISPR Associated(CAS Genes) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CRISPR and CRISPR Associated(CAS Genes) Industry Chain Analysis
4.1 CRISPR and CRISPR Associated(CAS Genes) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of CRISPR and CRISPR Associated(CAS Genes) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CRISPR and CRISPR Associated(CAS Genes) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CRISPR and CRISPR Associated(CAS Genes) Sales Market Share by Type (2018-2023)
6.3 Global CRISPR and CRISPR Associated(CAS Genes) Market Size Market Share by Type (2018-2023)
6.4 Global CRISPR and CRISPR Associated(CAS Genes) Price by Type (2018-2023)
7 CRISPR and CRISPR Associated(CAS Genes) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CRISPR and CRISPR Associated(CAS Genes) Market Sales by Application (2018-2023)
7.3 Global CRISPR and CRISPR Associated(CAS Genes) Market Size (M USD) by Application (2018-2023)
7.4 Global CRISPR and CRISPR Associated(CAS Genes) Sales Growth Rate by Application (2018-2023)
8 CRISPR and CRISPR Associated(CAS Genes) Market Segmentation by Region
8.1 Global CRISPR and CRISPR Associated(CAS Genes) Sales by Region
8.1.1 Global CRISPR and CRISPR Associated(CAS Genes) Sales by Region
8.1.2 Global CRISPR and CRISPR Associated(CAS Genes) Sales Market Share by Region
8.2 North America
8.2.1 North America CRISPR and CRISPR Associated(CAS Genes) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe CRISPR and CRISPR Associated(CAS Genes) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific CRISPR and CRISPR Associated(CAS Genes) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America CRISPR and CRISPR Associated(CAS Genes) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa CRISPR and CRISPR Associated(CAS Genes) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.1.2 Thermo Fisher Scientific CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.1.3 Thermo Fisher Scientific CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.1.4 Thermo Fisher Scientific Business Overview
9.1.5 Thermo Fisher Scientific CRISPR and CRISPR Associated(CAS Genes) SWOT Analysis
9.1.6 Thermo Fisher Scientific Recent Developments
9.2 Editas Medicine
9.2.1 Editas Medicine CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.2.2 Editas Medicine CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.2.3 Editas Medicine CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.2.4 Editas Medicine Business Overview
9.2.5 Editas Medicine CRISPR and CRISPR Associated(CAS Genes) SWOT Analysis
9.2.6 Editas Medicine Recent Developments
9.3 Caribou Biosciences
9.3.1 Caribou Biosciences CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.3.2 Caribou Biosciences CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.3.3 Caribou Biosciences CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.3.4 Caribou Biosciences Business Overview
9.3.5 Caribou Biosciences CRISPR and CRISPR Associated(CAS Genes) SWOT Analysis
9.3.6 Caribou Biosciences Recent Developments
9.4 CRISPR therapeutics
9.4.1 CRISPR therapeutics CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.4.2 CRISPR therapeutics CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.4.3 CRISPR therapeutics CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.4.4 CRISPR therapeutics Business Overview
9.4.5 CRISPR therapeutics CRISPR and CRISPR Associated(CAS Genes) SWOT Analysis
9.4.6 CRISPR therapeutics Recent Developments
9.5 Intellia therapeutics, Inc.
9.5.1 Intellia therapeutics, Inc. CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.5.2 Intellia therapeutics, Inc. CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.5.4 Intellia therapeutics, Inc. Business Overview
9.5.5 Intellia therapeutics, Inc. CRISPR and CRISPR Associated(CAS Genes) SWOT Analysis
9.5.6 Intellia therapeutics, Inc. Recent Developments
9.6 Cellectis
9.6.1 Cellectis CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.6.2 Cellectis CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.6.3 Cellectis CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.6.4 Cellectis Business Overview
9.6.5 Cellectis Recent Developments
9.7 Horizon Discovery Plc
9.7.1 Horizon Discovery Plc CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.7.2 Horizon Discovery Plc CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.7.3 Horizon Discovery Plc CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.7.4 Horizon Discovery Plc Business Overview
9.7.5 Horizon Discovery Plc Recent Developments
9.8 Sigma Aldrich
9.8.1 Sigma Aldrich CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.8.2 Sigma Aldrich CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.8.3 Sigma Aldrich CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.8.4 Sigma Aldrich Business Overview
9.8.5 Sigma Aldrich Recent Developments
9.9 Precision Biosciences
9.9.1 Precision Biosciences CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.9.2 Precision Biosciences CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.9.3 Precision Biosciences CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.9.4 Precision Biosciences Business Overview
9.9.5 Precision Biosciences Recent Developments
9.10 Genscript
9.10.1 Genscript CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.10.2 Genscript CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.10.3 Genscript CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.10.4 Genscript Business Overview
9.10.5 Genscript Recent Developments
9.11 Sangamo Biosciences Inc.
9.11.1 Sangamo Biosciences Inc. CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.11.2 Sangamo Biosciences Inc. CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.11.4 Sangamo Biosciences Inc. Business Overview
9.11.5 Sangamo Biosciences Inc. Recent Developments
9.12 Lonza Group Limited
9.12.1 Lonza Group Limited CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.12.2 Lonza Group Limited CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.12.3 Lonza Group Limited CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.12.4 Lonza Group Limited Business Overview
9.12.5 Lonza Group Limited Recent Developments
9.13 Integrated DNA Technologies
9.13.1 Integrated DNA Technologies CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.13.2 Integrated DNA Technologies CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.13.3 Integrated DNA Technologies CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.13.4 Integrated DNA Technologies Business Overview
9.13.5 Integrated DNA Technologies Recent Developments
9.14 New England Biolabs
9.14.1 New England Biolabs CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.14.2 New England Biolabs CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.14.3 New England Biolabs CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.14.4 New England Biolabs Business Overview
9.14.5 New England Biolabs Recent Developments
9.15 Origene Technologies
9.15.1 Origene Technologies CRISPR and CRISPR Associated(CAS Genes) Basic Information
9.15.2 Origene Technologies CRISPR and CRISPR Associated(CAS Genes) Product Overview
9.15.3 Origene Technologies CRISPR and CRISPR Associated(CAS Genes) Product Market Performance
9.15.4 Origene Technologies Business Overview
9.15.5 Origene Technologies Recent Developments
10 CRISPR and CRISPR Associated(CAS Genes) Market Forecast by Region
10.1 Global CRISPR and CRISPR Associated(CAS Genes) Market Size Forecast
10.2 Global CRISPR and CRISPR Associated(CAS Genes) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe CRISPR and CRISPR Associated(CAS Genes) Market Size Forecast by Country
10.2.3 Asia Pacific CRISPR and CRISPR Associated(CAS Genes) Market Size Forecast by Region
10.2.4 South America CRISPR and CRISPR Associated(CAS Genes) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of CRISPR and CRISPR Associated(CAS Genes) by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global CRISPR and CRISPR Associated(CAS Genes) Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of CRISPR and CRISPR Associated(CAS Genes) by Type (2024-2029)
11.1.2 Global CRISPR and CRISPR Associated(CAS Genes) Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of CRISPR and CRISPR Associated(CAS Genes) by Type (2024-2029)
11.2 Global CRISPR and CRISPR Associated(CAS Genes) Market Forecast by Application (2024-2029)
11.2.1 Global CRISPR and CRISPR Associated(CAS Genes) Sales (K Units) Forecast by Application
11.2.2 Global CRISPR and CRISPR Associated(CAS Genes) Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings